Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine, Low-Dose Cytarabine, and G-CSF in High-Risk MDS and AML
NCT00740181Phase 2Terminated
- Sponsor
- Brown University
- Start
- Aug 2008
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of decitabine, cytarabine in myelodysplastic syndrome (MDS), acute myeloid leukemia (AML), sponsored by Brown University. Started Aug 2008; status: terminated.
02
Drugs
decitabinecytarabine
03
Conditions
myelodysplastic syndrome (MDS)acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00740181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00740181.